Sarepta Therapeutics SRPT Earnings Call Transcripts

NASDAQ SRPT
$16.42 -0.82 (-4.76%)
At close: Nov 10, 2026 · 4:00 PM EST
24 earnings calls on file for Sarepta Therapeutics, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Sarepta Therapeutics Q2 2026 Earnings Call

Aug 5, 2026 11,102 words · 48 min read
  • Tamara ThorntonSenior Director of Investor Relations
  • Michael E. SeverinoChief Executive Officer
  • Dr. Louise Rodino-KlapacPresident of R&D and Technical Operations
  • Patrick MossChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Sarepta Therapeutics Earnings Call Transcripts

Calls24
LatestAug 5, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 24 Sarepta Therapeutics transcripts Register to get access to Sarepta Therapeutics’s earnings call transcripts.